
    
      An Open Label, Randomized, 2 -Period, 2-Treatment, 2 Sequence, Crossover, Single-Dose
      Bioequivalence Study of Esomeprazole Delayed Release Capsule 40 mg [Test Formulation, Torrent
      Pharmaceutical Ltd., India]Versus Nexium 40 mg Delayed Release Capsule containing
      Esomeprazole 40 mg. [Reference Formulation, AastraZeneca LP, USA] in Healthy Human Volunteers
      Under Fed Conditions.
    
  